rs16930609
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001429699.1(PDE3B):c.2887-4594A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.139 in 152,066 control chromosomes in the GnomAD database, including 1,728 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.14 ( 1728 hom., cov: 32)
Consequence
PDE3B
NM_001429699.1 intron
NM_001429699.1 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.23
Publications
7 publications found
Genes affected
PDE3B (HGNC:8779): (phosphodiesterase 3B) Enables 3',5'-cyclic-nucleotide phosphodiesterase activity. Involved in negative regulation of angiogenesis; negative regulation of cell adhesion; and negative regulation of lipid catabolic process. Located in membrane. Part of guanyl-nucleotide exchange factor complex. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.219 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| PDE3B | NM_001429699.1 | c.2887-4594A>C | intron_variant | Intron 14 of 14 | NP_001416628.1 | |||
| PDE3B | NM_001429700.1 | c.2887-4583A>C | intron_variant | Intron 14 of 14 | NP_001416629.1 | |||
| PDE3B | NR_190763.1 | n.3417-4594A>C | intron_variant | Intron 16 of 16 | ||||
| PDE3B | NR_190764.1 | n.3162-4594A>C | intron_variant | Intron 15 of 15 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|
Frequencies
GnomAD3 genomes AF: 0.139 AC: 21134AN: 151948Hom.: 1724 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
21134
AN:
151948
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.139 AC: 21172AN: 152066Hom.: 1728 Cov.: 32 AF XY: 0.142 AC XY: 10549AN XY: 74338 show subpopulations
GnomAD4 genome
AF:
AC:
21172
AN:
152066
Hom.:
Cov.:
32
AF XY:
AC XY:
10549
AN XY:
74338
show subpopulations
African (AFR)
AF:
AC:
9217
AN:
41432
American (AMR)
AF:
AC:
1985
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
AC:
603
AN:
3470
East Asian (EAS)
AF:
AC:
658
AN:
5176
South Asian (SAS)
AF:
AC:
632
AN:
4810
European-Finnish (FIN)
AF:
AC:
1423
AN:
10586
Middle Eastern (MID)
AF:
AC:
53
AN:
294
European-Non Finnish (NFE)
AF:
AC:
6291
AN:
67990
Other (OTH)
AF:
AC:
276
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
895
1790
2686
3581
4476
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
230
460
690
920
1150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
442
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.